The dawn of molecular medicine has brought many new challenges: How do these therapies work in patients? Why do they fail in some patients? Is their mechanism of action in patients the same as in ...

Primary pulmonary nuclear protein of the testis (NUT) midline carcinoma (NMC) is an extremely rare, highly aggressive thoracic malignancy that presents significant diagnostic and therapeutic ...

A recent study published in Engineering has shed light on a novel therapeutic target for improving anti-angiogenic treatment in colorectal cancer (CRC). The research, conducted by an international ...

Most tumors release various signaling molecules to support their incessant growth, invasion, and metastasis. Some of these molecules, known as tumor angiogenic factors (TAF), are able to stimulate the ...

A team led by Ludwig Lausanne's Tatiana Petrova, Jeremiah Bernier-Latmani and alum Christoph Cisarovsky identified a novel mechanism by which stem cells in intestinal tumors generate new blood vessels ...

The arrival of oral tyrosine kinase inhibitors (TKIs) radically changed the treatment paradigm in EGFR-mutated advanced non-small cell lung cancer (NSCLC), and this was followed by development of next ...

Most tumors release various signaling molecules to support their incessant growth, invasion, and metastasis. Some of these molecules, known as tumor angiogenic factors (TAF), are able to stimulate the ...

Researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) have identified a new molecular drug ...

Evaluation of immune related adverse events following extended interval dosing of immune checkpoint inhibitors. Results of various treatments in bilateral mouse tumor models. Treatment groups (N=5 ...

South Korean researchers have identified a new therapeutic target that could help overcome the limitations of anti-angiogenic ...